Video

Edward Fox, MD, Discusses the Extension Study of Alemtuzumab for MS

Neurology Reviews. 2013 April;21(4):602

 

Online-Only Materials

AttachmentSize
File 021040602.mp463.15 MB

Recommended Reading

Disputing the Zamboni Effect in MS
ICYMI Multiple Sclerosis
New and Noteworthy Information—January
ICYMI Multiple Sclerosis
When Should a Patient With MS Switch Therapies?
ICYMI Multiple Sclerosis
Teriflunomide Does Not Interfere With Seasonal Flu Vaccination in Patients With MS
ICYMI Multiple Sclerosis
New and Noteworthy Information—February
ICYMI Multiple Sclerosis
Emerging Oral Therapies for Multiple Sclerosis May Overshadow Older Drugs
ICYMI Multiple Sclerosis
Commentary—Oral MS Therapies Show Promise and Raise Questions
ICYMI Multiple Sclerosis
How Much MS Disease Activity Should Patients and Neurologists Tolerate?
ICYMI Multiple Sclerosis
New and Noteworthy Information—March
ICYMI Multiple Sclerosis
FROM AAN'S 2013 ANNUAL MEETING—Early Detection of PML May Improve Survival and Reduce Disability in MS
ICYMI Multiple Sclerosis